Jan. 3, 2024
by Halyna Buvailo
News
InVivo Biosystems, operating in the realm of CRISPR-edited animal models for biomedical research, has recently embarked on a new phase …
Jan. 4, 2024
by Andrii Buvailo
News
In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This …
Jan. 11, 2024
by Illia Petrov
News
Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic …
Sept. 18, 2020
by Andrii Buvailo
Interview
The application of next-generation data analytics tools, powered by machine learning and artificial intelligence (AI) components, has become a long-term …
May 6, 2022
by Bohdana Sokolova, Andrii Buvailo
Biopharma insight
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
Jan. 3, 2022
by Andrii Buvailo
Biopharma insight
Deep Knowledge Group, a UK-based consortium of commercial and non-for-profit companies in the domain of longevity industry and deep tech …
Oct. 6, 2023
by Andrii Buvailo
Biopharma insight
From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears …
May 15, 2024
by BiopharmaTrend
News
Nabla Bio, a biotechnology firm specializing in generative protein design, has successfully closed a $26 million Series A financing round, …
Sept. 24, 2021
by Illia Petrov, Darina Abdulina
Biopharma insight
Over 2020-2021 we have seen a remarkable parade of artificial intelligence (AI), focused on discovering novel therapeutics, going public. This …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
Sept. 28, 2020
by Andrii Buvailo
Interview
Recently, COVAXX announced it would soon enter human trials as the company is focused on rapidly developing a Multitope Peptide-based …
Nov. 20, 2022
by Bohdana Sokolova
Biopharma insight
Despite the economic situation and political climate in 2022, such fields as drug discovery and biotech keep evolving and bringing …